Home > Insider Trading > Filing (0001062993-23-003511)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1907685	Comera Life Sciences Holdings Inc.	CMRA	Pharmaceutical Preparations (2834)	874706968

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1926230	James Sherblom	C/O Comera Life Sciences Holdings, Inc. 12 Gill Street, Suite 4650 Woburn MA 01801		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-01-04	81,081	$1.23	452,244	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (Right to Buy)	Acquisiton	2023-01-04	81,081	$0.25	162,162	$1.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
81,081	2023-01-04	2028-01-04	No	4	P	Direct

Footnotes

This Form 4/A is being filed to (i) correct a typographical error in the transaction code disclosed in Column 3 in Table I and Column 4 in Table II in the original Form 4, filed on January 6, 2023, from "A" to "P" and (ii) correct a typographical error in the power-of-attorney of the reporting person.
The reporting person entered into a Securities Purchase Agreement with the Issuer on January 2, 2023, pursuant to which, on January 4, 2023, the reporting person acquired an aggregate of 81,081 units (the "Units") for a purchase price of $1.48 per Unit. Each Unit consists of one share of common stock, par value $0.0001 per share (the "Common Stock"), and one warrant (the "Warrants") to purchase two shares of Common Stock (the "Warrant Shares") at an exercise price of $1.23 per share. Each Warrant is immediately exercisable and expires five years from the date of issuance. The purchase price for each Unit includes $0.125 for each Warrant Share, or $0.25 per Warrant, in accordance with Nasdaq rules.
The exercisability of the Warrants is subject to a 9.99% beneficial ownership limitation.